Alzheimer's Drugs Global Market Report 2025

Alzheimer's Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alzheimer's drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for alzheimer's drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alzheimer's drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drugs: Donepezil; Rivastigmine; Galantamine; Memantine

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

3) By Application: Early To Moderate Stages; Moderate To Severe Stages

Subsegments:

1) By Donepezil: Oral Tablets; Oral Solution

2) By Rivastigmine: Oral Capsules; Oral Solution; Transdermal Patches

3) By Galantamine: Oral Tablets; Oral Solution; Extended-Release Capsules

4) By Memantine: Oral Tablets; Oral Solution; Extended-Release Capsules

Companies Mentioned: AbbVie Inc.; Daiichi Sankyo Company Limited; F Hoffmann-La Roche AG; Merck & Co Inc.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Alzheimer's Drugs Market Characteristics
3. Alzheimer's Drugs Market Trends And Strategies
4. Alzheimer's Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Alzheimer's Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Alzheimer's Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Alzheimer's Drugs Market Growth Rate Analysis
5.4. Global Alzheimer's Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Alzheimer's Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Alzheimer's Drugs Total Addressable Market (TAM)
6. Alzheimer's Drugs Market Segmentation
6.1. Global Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Donepezil
Rivastigmine
Galantamine
Memantine
6.2. Global Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.3. Global Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early To Moderate Stages
Moderate To Severe Stages
6.4. Global Alzheimer's Drugs Market, Sub-Segmentation Of Donepezil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Solution
6.5. Global Alzheimer's Drugs Market, Sub-Segmentation Of Rivastigmine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Capsules
Oral Solution
Transdermal Patches
6.6. Global Alzheimer's Drugs Market, Sub-Segmentation Of Galantamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Solution
Extended-Release Capsules
6.7. Global Alzheimer's Drugs Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Solution
Extended-Release Capsules
7. Alzheimer's Drugs Market Regional And Country Analysis
7.1. Global Alzheimer's Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Alzheimer's Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Alzheimer's Drugs Market
8.1. Asia-Pacific Alzheimer's Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Alzheimer's Drugs Market
9.1. China Alzheimer's Drugs Market Overview
9.2. China Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Alzheimer's Drugs Market
10.1. India Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Alzheimer's Drugs Market
11.1. Japan Alzheimer's Drugs Market Overview
11.2. Japan Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Alzheimer's Drugs Market
12.1. Australia Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Alzheimer's Drugs Market
13.1. Indonesia Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Alzheimer's Drugs Market
14.1. South Korea Alzheimer's Drugs Market Overview
14.2. South Korea Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Alzheimer's Drugs Market
15.1. Western Europe Alzheimer's Drugs Market Overview
15.2. Western Europe Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Alzheimer's Drugs Market
16.1. UK Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Alzheimer's Drugs Market
17.1. Germany Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Alzheimer's Drugs Market
18.1. France Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Alzheimer's Drugs Market
19.1. Italy Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Alzheimer's Drugs Market
20.1. Spain Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Alzheimer's Drugs Market
21.1. Eastern Europe Alzheimer's Drugs Market Overview
21.2. Eastern Europe Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Alzheimer's Drugs Market
22.1. Russia Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Alzheimer's Drugs Market
23.1. North America Alzheimer's Drugs Market Overview
23.2. North America Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Alzheimer's Drugs Market
24.1. USA Alzheimer's Drugs Market Overview
24.2. USA Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Alzheimer's Drugs Market
25.1. Canada Alzheimer's Drugs Market Overview
25.2. Canada Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Alzheimer's Drugs Market
26.1. South America Alzheimer's Drugs Market Overview
26.2. South America Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Alzheimer's Drugs Market
27.1. Brazil Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Alzheimer's Drugs Market
28.1. Middle East Alzheimer's Drugs Market Overview
28.2. Middle East Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Alzheimer's Drugs Market
29.1. Africa Alzheimer's Drugs Market Overview
29.2. Africa Alzheimer's Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Alzheimer's Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Alzheimer's Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Alzheimer's Drugs Market Competitive Landscape And Company Profiles
30.1. Alzheimer's Drugs Market Competitive Landscape
30.2. Alzheimer's Drugs Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Alzheimer's Drugs Market Other Major And Innovative Companies
31.1. Biogen Inc.
31.2. AstraZeneca PLC
31.3. Eisai Co Ltd.
31.4. Eli Lilly and Company
31.5. H Lundbeck A/S
31.6. Pfizer Inc.
31.7. Allergan PLC.
31.8. Johnson & Johnson
31.9. Lupin Pharmaceuticals Inc.
31.10. Actiza Pharmaceutical Private Limited
31.11. Neurotrope Inc.
31.12. AC Immune SA
31.13. Adamas Pharmaceuticals Inc
31.14. Alzheon Inc.
31.15. Anavex Life Sciences Corp
32. Global Alzheimer's Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Alzheimer's Drugs Market
34. Recent Developments In The Alzheimer's Drugs Market
35. Alzheimer's Drugs Market High Potential Countries, Segments and Strategies
35.1 Alzheimer's Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Alzheimer's Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Alzheimer's Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings